Ningbo Sanxing Medical Electric Co.,Ltd. (601567.SS)
CNY 33.48
(0.93%)
CNY 33.48
(0.93%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 2.5 Billion CNY | 40.02% |
| 2022 | 1.48 Billion CNY | 33.12% |
| 2021 | 1.03 Billion CNY | -25.01% |
| 2020 | 1.4 Billion CNY | -9.08% |
| 2019 | 1.17 Billion CNY | 94.74% |
| 2018 | 790.94 Million CNY | -25.34% |
| 2017 | 1.13 Billion CNY | 1.59% |
| 2016 | 1.08 Billion CNY | 37.35% |
| 2015 | 806.16 Million CNY | 51.58% |
| 2014 | 535.77 Million CNY | 39.79% |
| 2013 | 367.56 Million CNY | 6.73% |
| 2012 | 333.82 Million CNY | 33.07% |
| 2011 | 268.88 Million CNY | 4.36% |
| 2010 | 232.19 Million CNY | 13.75% |
| 2009 | 225.19 Million CNY | 111.72% |
| 2008 | 105.17 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 894.54 Million CNY | 122.1% |
| 2024 Q3 | 779.17 Million CNY | -23.31% |
| 2024 Q1 | 506.91 Million CNY | -16.36% |
| 2023 Q4 | 424.83 Million CNY | -35.41% |
| 2023 FY | - CNY | 40.02% |
| 2023 Q1 | 381.12 Million CNY | 71.98% |
| 2023 Q2 | 693.14 Million CNY | 81.87% |
| 2023 Q3 | 657.76 Million CNY | -5.1% |
| 2022 Q2 | 219.81 Million CNY | -22.93% |
| 2022 Q1 | 285.21 Million CNY | 177.79% |
| 2022 FY | - CNY | 33.12% |
| 2022 Q4 | 221.61 Million CNY | -55.57% |
| 2022 Q3 | 498.8 Million CNY | 126.92% |
| 2021 Q1 | 215.96 Million CNY | -56.08% |
| 2021 Q2 | 359.94 Million CNY | 66.67% |
| 2021 FY | - CNY | -25.01% |
| 2021 Q4 | 102.67 Million CNY | -56.32% |
| 2021 Q3 | 235.04 Million CNY | -34.7% |
| 2020 Q2 | 456.11 Million CNY | 92.5% |
| 2020 Q1 | 236.94 Million CNY | -55.11% |
| 2020 FY | - CNY | -9.08% |
| 2020 Q3 | 366.29 Million CNY | -19.69% |
| 2020 Q4 | 491.68 Million CNY | 34.23% |
| 2019 FY | - CNY | 94.74% |
| 2019 Q2 | 432.49 Million CNY | 86.36% |
| 2019 Q3 | 301.82 Million CNY | -30.21% |
| 2019 Q4 | 527.86 Million CNY | 74.89% |
| 2019 Q1 | 232.07 Million CNY | 82.95% |
| 2018 Q2 | 177 Million CNY | 31.35% |
| 2018 Q1 | 134.75 Million CNY | -74.44% |
| 2018 FY | - CNY | -25.34% |
| 2018 Q4 | 126.85 Million CNY | -53.05% |
| 2018 Q3 | 270.19 Million CNY | 52.65% |
| 2017 FY | - CNY | 1.59% |
| 2017 Q4 | 527.14 Million CNY | 134.94% |
| 2017 Q3 | 224.37 Million CNY | 2.19% |
| 2017 Q2 | 219.57 Million CNY | 102.72% |
| 2017 Q1 | 108.31 Million CNY | -80.5% |
| 2016 Q3 | 194.29 Million CNY | -2.65% |
| 2016 Q2 | 199.57 Million CNY | 91.99% |
| 2016 Q1 | 103.95 Million CNY | -71.38% |
| 2016 FY | - CNY | 37.35% |
| 2016 Q4 | 555.54 Million CNY | 185.92% |
| 2015 Q1 | 62.13 Million CNY | -69.58% |
| 2015 Q2 | 198.88 Million CNY | 220.09% |
| 2015 Q4 | 363.21 Million CNY | 127.63% |
| 2015 Q3 | 159.56 Million CNY | -19.77% |
| 2015 FY | - CNY | 51.58% |
| 2014 Q4 | 204.25 Million CNY | 33.77% |
| 2014 Q3 | 152.68 Million CNY | 32.8% |
| 2014 Q2 | 114.97 Million CNY | 192.37% |
| 2014 Q1 | 39.32 Million CNY | -74.05% |
| 2014 FY | - CNY | 39.79% |
| 2013 Q1 | 40.33 Million CNY | -73.21% |
| 2013 FY | - CNY | 6.73% |
| 2013 Q4 | 151.55 Million CNY | 72.7% |
| 2013 Q3 | 87.75 Million CNY | 35.2% |
| 2013 Q2 | 64.91 Million CNY | 60.91% |
| 2012 FY | - CNY | 33.07% |
| 2012 Q3 | 62.29 Million CNY | -21.38% |
| 2012 Q4 | 150.6 Million CNY | 141.76% |
| 2012 Q2 | 79.23 Million CNY | 145.44% |
| 2012 Q1 | 32.28 Million CNY | -63.72% |
| 2011 Q3 | 63.38 Million CNY | 14.57% |
| 2011 Q1 | 36.79 Million CNY | -59.32% |
| 2011 Q2 | 55.32 Million CNY | 50.34% |
| 2011 Q4 | 88.97 Million CNY | 40.38% |
| 2011 FY | - CNY | 4.36% |
| 2010 FY | - CNY | 13.75% |
| 2010 Q4 | 90.47 Million CNY | 22.88% |
| 2010 Q3 | 73.62 Million CNY | 0.0% |
| 2009 FY | - CNY | 111.72% |
| 2008 FY | - CNY | 0.0% |